NCT06965114 2026-06-03Testing the Combination of Anti-cancer Drugs, Tovorafenib Plus Rituximab, in Patients With Hairy Cell LeukemiaNational Cancer Institute (NCI)Phase 1/2 Recruiting84 enrolled